Roth Capital Comments on Buy-Rated Galena (GALE) Following CEO Transition
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Galena Biopharma (GALE) CEO Was Fired Due to Stock Promotion Campaign - TheStreet
August 21, 2014 7:58 AM EDTGalena Biopharma (NASDAQ: GALE) CEO Mark Ahn was fired, according to reports in TheStreet.com (link). The article links... More
Galena Biopharma (GALE) Names Mark W. Schwartz as CEO
August 21, 2014 7:05 AM EDTGalena Biopharma (Nasdaq: GALE) announced that Mark W. Schwartz, Ph.D., has been appointed as President and Chief Executive Officer, effective immediately. Dr. Schwartz was previously Galena's Executive Vice President and Chief Operating Officer. He replaces Mark J. Ahn, Ph.D. who has resigned as the President and CEO and as a director of the company to pursue other long held personal and professional goals. It is expected that Dr. Schwartz will also be appointed to Galena's Board of Directors.
"Dr. Schwartz brings more than 30 years of experience in the biotechnology... More



